Unlocking the Gut Brain Axis: How GLP-1 Rewires Disorders and Transforms Mental Health

Targeting the brain

Research indicates that GLP-1 shapes the perception of and preference for tastes like sweetness via gut-brain axis signaling [13]. This process involves the detection of peripheral taste signals, their central processing, and complex hormonal-neural interactions.

Recently developed therapies based on analogs of the gut hormone glucagon-like peptide-1 ( GLP-1 ) have transformed the medical management of obesity, leading both to a degree of weight loss that rivals bariatric surgery and a reduction in morbidity and mortality associated with obesity-related complications.

The central signaling pathways related to metabolism

The gut-brain axis is the primary pathway through which GLP-1 exerts its central effects. Through this axis , GLP-1 stimulates insulin secretion, enhances insulin sensitivity, delays gastric emptying, suppresses appetite, and influences lipid metabolism [5].

The gut-brain axis , which mediates bidirectional communication between the gastrointestinal system and central nervous system (CNS), plays a fundamental role in multiple areas of physiology including regulating appetite, metabolism, and gastrointestinal function. The biology of the gut-brain axis is central to the efficacy of glucagon-like peptide-1 (GLP-1)-based therapies, which are now ...

Decoding The Gut

This integrated signaling network, now acknowledged as the gut - brain -microbiome axis , manages nutrient detection, appetite regulation, inflammation, and energy equilibrium, highlighting that GLP-1 acts at the convergence of metabolic and neuroendocrine control [8-10].

This review thus consolidates existing preclinical and clinical studies to investigate the relationships between GLP1 -RAs, the gut microbiome, and the gut-brain axis (GBA). The first parts present findings that show how different GLP-1 analogs affect microbial diversity, composition, and metabolic function. Following this, the review discusses how alterations in the gut microbiome due to GLP ...

Neurobiological Mechanisms and Therapeutic Potential of Glucagon

The hormone glucagon-like peptide-1 ( GLP-1 ), a key mediator in the gut-brain axis , has emerged as a promising therapeutic target due to its dual role in regulating both energy balance and reward pathways [26, 27].

Glucagon‐like‐peptide‐1 ( GLP‐1 ) derived from gut enteroendocrine cells and a discrete population of neurons in the caudal medulla acts through humoral and neural pathways to regulate satiety, gastric motility and pancreatic endocrine function. These ...

Key Details About Glp-1 And Gut-Brain Axis Disorders Research

Neurodegenerative disorders , including Alzheimer's disease (AD), Parkinson's disease (PD), stroke, and depression, are marked by progressive neuronal dysfunction and loss, yet current treatments remain largely symptomatic with limited disease-modifying efficacy. Glucagon-like peptide-1 ( GLP-1 ), an incretin hormone traditionally associated with metabolic regulation, has emerged as a ...

The brain - gut neurocircuitry is proving to be finely involved in a wide range of physiological functions. In this issue of Neuron, Ren et al. show that adrenergic signaling suppresses postprandial glucagon-like peptide 1 ( GLP-1 ) secretion. This, in turn, raises circulating glucose levels and impairs brain glucose uptake and cognitive function.